Targeted co-delivery of curcumin and erlotinib by MoS(2) nanosheets for the combination of synergetic chemotherapy and photothermal therapy of lung cancer

BACKGROUND: Curcumin (Cur), a bioactive component of Chinese traditional medicine, has demonstrated inhibitory properties against cancer cell proliferation while synergistically enhancing the anticancer efficacy of erlotinib (Er). However, the individual limitations of both drugs, including poor aqu...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zhihuai, Wei, Xinqi, Zheng, Yunru, Zhang, Zongwei, Gu, Wang, Liao, Wenjun, Zhang, Hua, Wang, Xiaoying, Liu, Jian, Li, Hua, Xu, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505307/
https://www.ncbi.nlm.nih.gov/pubmed/37717020
http://dx.doi.org/10.1186/s12951-023-02099-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505307/
https://www.ncbi.nlm.nih.gov/pubmed/37717020
http://dx.doi.org/10.1186/s12951-023-02099-4

Ejemplares similares